Security Snapshot

Cue Biopharma, Inc. - Common Stock (CUE) Institutional Ownership

CUSIP: 22978P205

13F Institutional Holders and Ownership History from Q1 2026 to Q2 2026

Latest Period

Q2 2026

Institutions Reporting

48

Shares (Excl. Options)

1,641,349

Price

$31.56

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+1,638,532
Value change
+$51,716,970
Number of holders
48
Issuer context Names, identifiers, and filing context for this profile. 2 identity fields
Shares outstanding
4,197,471
SEC-reported price per share
$36.78
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • CUE - Cue Biopharma, Inc. - Common Stock is tracked under CUSIP 22978P205.
  • 48 institutions reported positions in Q2 2026.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 2 to 48 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $391 to $51,799,609.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 48 institutions filings for Q2 2026.

Open SEC evidence

Security key

22978P205

Latest holder period

Q2 2026

13F holders

48

13D/G owners

1

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
1
Security
CUE
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
DRIEHAUS CAPITAL MANAGEMENT LLC 7% $10,745,056 292,144 DRIEHAUS CAPITAL MANAGEMENT LLC 30 Jun 2026

As of 30 Jun 2026, 48 institutional investors reported holding 1,641,349 shares of Cue Biopharma, Inc. - Common Stock (CUE). This represents 39% of the company’s total 4,197,471 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
39%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Bleichroeder LP 8.8% 370,682 2.1% $11,698,724
Driehaus Capital Management LLC 7% 292,144 0.05% $9,220,065
VANGUARD CAPITAL MANAGEMENT LLC 3.9% 161,700 0% $5,103,252
Ikarian Capital, LLC 2.5% 104,364 0.54% $3,293,728
Tetragon Partners GP Ltd 2.2% 93,819 0.48% $2,960,928
STEMPOINT CAPITAL LP 1.6% 66,995 0.37% $2,114,362
BlackRock, Inc. 1.4% 57,807 0% $1,824,389
ADAR1 Capital Management, LLC 1.3% 55,193 0.08% $1,741,891
Lion Point Capital, LP 1.3% 52,928 8% $1,670,408
Squadron Capital Management LLC 1.2% 50,000 0.54% $1,578,000
DIADEMA PARTNERS LP 1.2% 48,369 0.58% $1,526,526
GEODE CAPITAL MANAGEMENT, LLC 1.1% 47,824 0% $1,509,457
BOOTHBAY FUND MANAGEMENT, LLC 0.75% 31,459 0.02% $992,846
UBS Group AG 0.64% 26,700 0% $842,652
CITADEL ADVISORS LLC 0.61% 25,633 0% $808,977
VANGUARD FIDUCIARY TRUST CO 0.58% 24,476 0% $772,463
Texas Capital Bank Wealth Management Services Inc 0.55% 22,881 0.04% $722,124
RENAISSANCE TECHNOLOGIES LLC 0.35% 14,689 0% $463,585
Persistent Asset Partners Ltd 0.29% 12,332 0.12% $389,198
Robertson Stephens Wealth Management, LLC 0.27% 11,133 0.01% $351,357
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.26% 11,003 0% $347,255
Seven Fleet Capital Management LP 0.25% 10,702 0.06% $337,755
NORTHERN TRUST CORP 0.22% 9,122 0% $287,890
ADVISORY RESEARCH INC 0.2% 8,573 0.03% $270,564
STIFEL FINANCIAL CORP 0.2% 8,218 0% $259,360

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
2
Latest
Q2 2026
Rows shown
1-2 of 2
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 1,641,349 $51,799,609 +$51,716,970 $31.56 48
2026 Q1 1,700 $391 +$391 $0.23 2
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .